How Does Routine Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Modify the Current Management of Prostate Cancer? A Multidisciplinary View
A group of Dutch medical specialists discussed on how to diagnose metastatic hormone-sensitive prostate cancer and choose the most appropriate treatment for patients with this condition. It was concluded that imaging based on Prostate-specific membrane antigen (PSMA) positron emission tomography (PET) helps determine appropriate treatment options, with most experts supporting treatment adjustments based on PSMA-PET/computed tomography (CT) results. However, there is still some uncertainty about the criteria for interpreting the extent of metastatic disease with PSMA-PET/CT.
Authors
- Chris H. Bangma (ORCID: https://orcid.org/0000-0002-7787-1969)
- Tessa van Elst (ORCID: https://orcid.org/0000-0001-6495-6130)
- Jules Lavalaye (ORCID: https://orcid.org/0000-0001-7475-1489)
- Peter-Paul Michiel Willemse (ORCID: https://orcid.org/0000-0002-6364-9224)
- Joyce M. van Dodewaard-de Jong (ORCID: https://orcid.org/0000-0003-2847-9060)
- Robert J. van Soest (ORCID: https://orcid.org/0000-0002-8504-5675)
- Walter Noordzij (ORCID: https://orcid.org/0000-0001-6386-5499)
- Henk G. van der Poel (ORCID: https://orcid.org/0000-0002-8772-1120)
- Igle J. de Jong (ORCID: https://orcid.org/0000-0002-3444-5548)
- Aart Beeker (ORCID: https://orcid.org/0000-0003-4133-769X)
- Els Dewulf
- Michel van Kruchten (ORCID: https://orcid.org/0000-0003-0897-2747)
- Theo Veninga
- E. Van Limbergen
- Daniela E. Oprea‐Lager (ORCID: https://orcid.org/0000-0001-9447-2305)
- Niven Mehra (ORCID: https://orcid.org/0000-0002-4794-1831)
- R. Jeroen A. van Moorselaar (ORCID: https://orcid.org/0000-0002-2559-9254)
- Maarten L. Donswijk (ORCID: https://orcid.org/0000-0003-2028-9713)
- Kim C. de Vries
- Robert J. Hoekstra (ORCID: https://orcid.org/0000-0002-9128-0444)
- Thomas Kerkhofs (ORCID: https://orcid.org/0000-0001-8583-6162)
- Jurgen J. Fütterer (ORCID: https://orcid.org/0000-0001-6800-2879)
- Irma M. Oving (ORCID: https://orcid.org/0000-0002-6149-2171)
- Paul Hamberg (ORCID: https://orcid.org/0000-0002-8223-0250)
- Pim J. van Leeuwen (ORCID: https://orcid.org/0000-0002-5531-6104)
- Linda Heijmen (ORCID: https://orcid.org/0000-0003-1453-3337)
- Roderick C.N. van den Bergh
- Steve Boudewijns (ORCID: https://orcid.org/0000-0003-4201-3507)
- Shafak Aluwini
- Joep G.H. van Roermund (ORCID: https://orcid.org/0000-0002-6067-7502)
- Herman Stoevelaar (ORCID: https://orcid.org/0000-0002-2020-8023)
- Derya Yakar (ORCID: https://orcid.org/0000-0002-4920-9441)
- Debbie Robbrecht (ORCID: https://orcid.org/0000-0003-2490-9991)
- Inge M. van Oort (ORCID: https://orcid.org/0000-0002-8002-1869)
- André N. Vis (ORCID: https://orcid.org/0000-0003-3419-3368)
- Daphne Luijendijk-de Bruin
- Tom van der Hulle (ORCID: https://orcid.org/0000-0002-2296-1828)
- Jens Voortman
- Addy C.M. van de Luijtgaarden (ORCID: https://orcid.org/0000-0001-8716-1509)
- J C Koen van der Mijn
- Franchette van den Berkmortel
- Tom Budiharto
- Eva E. Schaake
Institutions
- University Medical Center Groningen (NL)
- Radboud University Nijmegen (NL)
- Leiden University Medical Center (NL)
- Maastricht University Medical Centre (NL)
- Catharina Ziekenhuis (NL)
- Erasmus MC (NL)
- Radboud University Medical Center (NL)
- The Netherlands Cancer Institute (NL)
- University Medical Center Utrecht (NL)
- Maastricht University (NL)
- Spaarne Ziekenhuis (NL)
- Martini Ziekenhuis (NL)
- Canisius-Wilhelmina Ziekenhuis (NL)
- Instituut Verbeeten (NL)
- Ziekenhuis Groep Twente (NL)
- Meander Medisch Centrum (NL)
- Maastro Clinic (NL)
- Spaarne Gasthuis (NL)
- Erasmus University Rotterdam (NL)
Publication Details
- Journal
- European Urology Open Science
- Published
- 2025-04-08
- DOI
- https://doi.org/10.1016/j.euros.2025.03.007
- Citations
- 3
- Primary Topic
- Prostate Cancer Treatment and Research
- Type
- article
- Field-Weighted Citation Impact
- 4.56
Funders
- Astellas Pharma, Netherlands